[Infections in bone marrow transplantation]

Rev Invest Clin. 2005 Mar-Apr;57(2):381-6.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adenoviridae Infections / drug therapy
  • Adenoviridae Infections / epidemiology
  • Antifungal Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Bone Marrow Transplantation* / adverse effects
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / transmission
  • Epstein-Barr Virus Infections / drug therapy
  • Epstein-Barr Virus Infections / epidemiology
  • Epstein-Barr Virus Infections / transmission
  • Herpesvirus 4, Human / physiology
  • Humans
  • Immunocompromised Host
  • Immunosuppression Therapy / adverse effects
  • Infections / epidemiology*
  • Infections / etiology
  • Infections / transmission
  • Mycoses / drug therapy
  • Mycoses / epidemiology
  • Mycoses / etiology
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / microbiology
  • Postoperative Complications / virology
  • Postoperative Period
  • Risk Factors
  • Transplantation Conditioning / adverse effects
  • Transplantation, Autologous
  • Transplantation, Homologous / adverse effects
  • Virus Activation

Substances

  • Antifungal Agents
  • Antiviral Agents